ArticleCancer immunology, immunotherapy : CII2009

Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer.

Ichiya Honma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.